Fernandez-Hernando, Carlos

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., Goedeke, L., Liu, X., et al. (2011) · Nature

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 706

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 690

Smooth Muscle Cell Reprogramming in Aortic Aneurysms

Chen, P.-Y., Qin, L., Li, G., Malagon-Lopez, J., Wang, Z., Bergaya, S., Gujja, S., Caulk, A. W., Murtada, S.-I., Zhang, X., et al. (2020) · Cell Stem Cell

Aortic aneurysm repair treatmentsAortic Disease and Treatment Approaches

Cited by 214

Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy

McConnell, M. J., Kawaguchi, N., Kondo, R., Sonzogni, A., Licini, L., Valle, C., Bonaffini, P. A., Sironi, S., Alessio, M. G., Previtali, G., et al. (2021) · Journal of Hepatology

COVID-19 Clinical Research StudiesDrug-Induced Hepatotoxicity and Protection

Cited by 111

Disulfiram Treatment Normalizes Body Weight in Obese Mice

Bernier, M., Mitchell, S. J., Wahl, D., Diaz, A., Singh, A., Seo, W., Wang, M., Ali, A., Kaiser, T., Price, N. L., et al. (2020) · Cell Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 85

Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome

Bernier, M., Harney, D., Koay, Y. C., Diaz, A., Singh, A., Wahl, D., Pulpitel, T., Ali, A., Guiterrez, V., Mitchell, S. J., et al. (2020) · npj Aging and Mechanisms of Disease

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 26